Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes.

Maria Teresa Voso, Emiliano Fabiani, Francesco D'Alo', Francesco Guidi, Annalisa Di Ruscio, Livio Pagano, Simona Sica, Mariangela Greco, Stefan Hohaus, G. Leone

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

59 Citazioni (Scopus)


BACKGROUND: Polymorphisms in genes involved in detoxification and DNA-repair pathways may modify the individual's risk for genomic damage, and, as a consequence, the risk of developing malignant diseases. PATIENTS AND METHODS: We performed a case-control study including 160 cases of acute myeloid leukaemia (AML) and 162 matched controls to test the impact of six genomic polymorphisms on the risk to develop AML and/or therapy-related AML. RESULTS: We found a significantly higher prevalence of the polymorphic variants RAD51-G135C and CYP3A4-A-290G genes in AML cases, when compared with controls (P = 0.02 and P = 0.04), increasing the risk of AML 2.1-folds (95% CI: 1.1-4.0) and 3.2-fold (95% CI: 1.1-11.5), respectively. Carriers of both the RAD51-G135C and CYP3A4-A-290G variants were at highest AML risk (P = 0.003; OR:13,6; 95% CI: 2.0-585.5), suggesting a synergistic effect between these polymorphisms. CONCLUSIONS: These results suggest that polymorphic variants in DNA-repair and detoxification enzymes may co-operate in modulating the individual's risk of AML.
Lingua originaleEnglish
pagine (da-a)1523-1528
Numero di pagine6
RivistaAnnals of Oncology
Stato di pubblicazionePubblicato - 2007


  • AML
  • Polymorphism


Entra nei temi di ricerca di 'Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes.'. Insieme formano una fingerprint unica.

Cita questo